留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码
x 关闭 永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

MDR1基因多态性和单倍体对肾移植术后稳定期患者他克莫司浓度/剂量比值的影响

张燕青,  陈锦珊,  李金雨,  林秀丽,  石鹤坤,  林小凤

downloadPDF
文章导航 > 药学实践与服务  > 2015 >  33(5): 415-418
张燕青, 陈锦珊, 李金雨, 林秀丽, 石鹤坤, 林小凤. MDR1基因多态性和单倍体对肾移植术后稳定期患者他克莫司浓度/剂量比值的影响[J]. 药学实践与服务, 2015, 33(5): 415-418. doi: 10.3969/j.issn.1006-0111.2015.05.008
引用本文: 张燕青, 陈锦珊, 李金雨, 林秀丽, 石鹤坤, 林小凤. MDR1基因多态性和单倍体对肾移植术后稳定期患者他克莫司浓度/剂量比值的影响[J]. 药学实践与服务, 2015, 33(5): 415-418. doi: 10.3969/j.issn.1006-0111.2015.05.008
shu
ZHANG Yanqing, CHEN Jinshan, LI Jinyu, LIN Xiuli, SHI Hekun, LIN Xiaofeng. Influence of multidrug resistant gene polymorphisms and haplotype on blood concentration of tacrolimus in individuals in stable phases after renal transplantation[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(5): 415-418. doi: 10.3969/j.issn.1006-0111.2015.05.008
Citation: ZHANG Yanqing, CHEN Jinshan, LI Jinyu, LIN Xiuli, SHI Hekun, LIN Xiaofeng. Influence of multidrug resistant gene polymorphisms and haplotype on blood concentration of tacrolimus in individuals in stable phases after renal transplantation[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(5): 415-418. doi: 10.3969/j.issn.1006-0111.2015.05.008
shu

MDR1基因多态性和单倍体对肾移植术后稳定期患者他克莫司浓度/剂量比值的影响

doi: 10.3969/j.issn.1006-0111.2015.05.008
  • 1.

    解放军175医院, 药学科, 福建 漳州 363000

  • 2.

    解放军175医院, 泌尿外科, 福建 漳州 363000

基金项目: 漳州市科学技术局科研课题(ZZ2012J27)

Influence of multidrug resistant gene polymorphisms and haplotype on blood concentration of tacrolimus in individuals in stable phases after renal transplantation

  • 1.

    No.175 Hospital of PLA, Department of Pharmacy, Zhangzhou 363000, China

  • 2.

    No.175 Hospital of PLA, Department of Urology, Zhangzhou 363000, China

  • 摘要: 目的 探讨MDR1 C1236T、G2677T/A和C3435T 基因多态性和单倍体对中国汉族肾移植术后稳定期患者他克莫司浓度/剂量比值的影响,为他克莫司个体化用药提供依据。 方法 采用PCR-基因测序法检测104例肾移植术后稳定期患者MDR1 C1236T、G2677T/A和C3435T 的基因多态性,采用均相酶免疫测定方法(EMIT法)测定他克莫司的谷浓度,比较不同基因型患者之间他克莫司血药浓度/(剂量×体质量)(C/D)比值。 结果 104例患者中,MDR1 C1236T、G2677T/A和C3435T突变频率分别为56.73%、55.77%和33.17%。MDR1 C3435T、MDR1 TTT单倍体与他克莫司C/D比值具有相关性(P<0.05)。CYP3A5*3*3患者中,MDR1 TTT单倍体与他克莫司C/D比值仍存在显著相关(P<0.05)。MDR1 C1236T、G2677T/A、CGC单倍体与他克莫司C/D比值无显著性差异(P>0.05)。 结论 MDR1 C3435T、MDR1 TTT单倍体与中国汉族肾移植术后稳定期患者他克莫司C/D比值具有显著相关性,是影响肾移植患者他克莫司浓度个体化差异的重要因素。
    Abstract: Objective To study the relevance between the polymorphisms and haplotype of multidrug resistant gene (MDR1) and the ratio of blood concentration/dosage in individuals treated by tacrolimus in stable phases post renal transplantation, and to provide data for personalized FK-506 administration. Methods The MDR1 C1236T, G2677T/A and C3435T genotypes of 104 renal transplantation patients were determined by PCR followed sequencing method. The blood concentration of tacrolimus was detected by EMIT method. The differences in concentration/ (dose×weight) (C/D) ratios were compared among all of the genotype groups treated by tacrolimus. Results In the 104 renal transplantation recipients, the frequency of MDR1 C1236T,G2677T/A and C3435T mutation alleles was 56.73%, 55.77% and 33.17%, respectively. A correlation was revealed among SNP of MDR1 C3435T, TTT haplotype and the C/D ratios (P<0.05). In patients of CYP3A5*3*3, A correlation was also found among TTT haplotype and the C/D ratios (P<0.05). No difference was found among the MDR1 C1236T, G2677T/A, CGC haplotype and the C/D ratios (P>0.05). Conclusion It is demonstrated that genetic polymorphisms of MDR1 C3435T and TTT haplotype are correlated with C/D ratio of tacrolimus in Chinese renal transplant patients in stable stage. These findings affect the dose-adjusted concentration of tacrolimus individually.
  • [1] Margreiter R. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study[J]. Lancet,2002,359:741-746.
    [2] Sandrini S, Aslam N, Tardanico R, et al. Tacrolimus versus cyclosporine for early steroid withdrawal after renal transplantation[J]. J Nephrol, 2012, 25(1):43-49.
    [3] Wallemacq P, Armstrong VW, Brunet M, et al. Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European Consensus Conference[J].Ther Drug Monit,2009,31(2):139-152.
    [4] Hoffmeyer S,Burk O,Von Richter O,et al. Functional polymorphisms of the human multidrug- resistance gene:multiple sequence variations and correlation of one allele with P- glycoprotein expression and activity in vivo[J]. Proc Natl Acad Sci (USA),2000,97(7):3473-3478.
    [5] 曾 明,邸晓辉,赵维娟,等. 五酯胶囊(片)对他克莫司血药浓度及药动学参数影响的Meta分析[J].解放军药学学报,2014,30(5):405-409.
    [6] 吴 雪,蔡 林,石姗平,等. 五酯胶囊对肾移植患者他克莫司血药浓度的影响[J].中国药房,2013,24(43):4094-4097.
    [7] 刘龙山,王长希,傅 茜,等. 五酯片用于肾移植患者对他克莫司药代动力学的影响及长期疗效观察[J]. 器官移植,2012,3(1):33-36.
    [8] 胡永芳,周宏灏. CYP3A4,CYP3A5和MDR1基因多态性对环抱素处置的影响[J].中国药理学通报,2005,21(3):257-261.
    [9] 李丹滢,方 芸. CYP3A4/5、ABCB1基因单倍型与中国肾移植患者他克莫司血药谷浓度相关性研究[J].药学与临床研究,2014,22(1):20-24.
    [10] Wu P, Ni X, Wang M, et al. Polymorphisms in CYP3A5*3 and MDR1, and haplotype modulate response to plasma levels of tacrolimus in Chinese renal transplant patients[J].Ann Transplant,2011, 16(1):54-60.
    [11] Glowacki F, Lionet A, Buob D, et al. CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on tacrolimus dose requirements and clinical outcome after renal transplantation[J]. Nephrol Dial Transplant,2011, 26(9):3046-3050.
    [12] Rong G, Jing L Deng L,et al.Influence of CYP3A5 and MDR1(ABCB1) polymorphisms on the pharmacokinetics of tacrolimus in Chinese renal transplant recipients[J]. Transplant Proc,2010, 42(9):3455-3458.
    [13] Cusinato DA, Lacchini R, Romao EA, et al. Relationship of CYP3A5 genotype and ABCB1 diplotype to tacrolimus disposition in Brazilian kidney transplant patients[J]. Br J Clin Pharmacol, 2014, 78(2):364-72.
  • [1] 唐淑慧, 凤美娟, 薛智霞, 鲁桂华.  帕博利珠单抗治疗所致免疫相关不良反应与中医体质的相关性研究 . 药学实践与服务, 2024, 42(5): 217-222. doi: 10.12206/j.issn.2097-2024.202311029
    [2] 王耀振, 徐灿, 吕顺莉, 田泾, 张东炜.  钾离子竞争性酸阻滞剂的药学特征研究进展 . 药学实践与服务, 2024, 42(7): 278-284. doi: 10.12206/j.issn.2097-2024.202306040
    [3] 张晶晶, 索丽娜, 郑兆红.  89例细菌性肝脓肿的临床特征及抗感染治疗分析 . 药学实践与服务, 2024, 42(6): 267-272. doi: 10.12206/j.issn.2097-2024.202302039
    [4] 刘丽艳, 余小翠, 孙传铎.  纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(): 1-6. doi: 10.12206/j.issn.2097-2024.202310044
    [5] 史生辉, 石飞, 雷琼, 王亚峰, 吴雪花.  青藏高原肺结核合并念珠菌感染患者的病原菌分布特点及耐药率分析 . 药学实践与服务, 2024, 42(6): 260-262, 272. doi: 10.12206/j.issn.2097-2024.202304014
    [6] 瞿文君, 白若楠, 崔力, 周琰.  基于联合库存的公立医院多院区药品采购模式分析 . 药学实践与服务, 2024, 42(7): 1-4. doi: 10.12206/j.issn.2097-2024.202401002
    [7] 陈炳辰, 佟达丰, 万苗, 闫飞虎, 姚建忠.  UPLC-MS/MS法测定小鼠血浆中紫杉醇脂肪酸酯前药及其药代动力学研究 . 药学实践与服务, 2024, 42(): 1-5. doi: 10.12206/j.issn.2097-2024.202404082
    [8] 王雪莲, 郑斯莉, 李志勇, 罗亨宇, 缪朝玉.  全身过表达人METRNL基因小鼠模型的构建与验证 . 药学实践与服务, 2024, 42(5): 198-202, 222. doi: 10.12206/j.issn.2097-2024.202311014
    [9] 丁千雪, 尚圣兰, 余梦辰, 余爱荣.  机器学习在肾病综合征患者他克莫司个体化用药中的应用 . 药学实践与服务, 2024, 42(6): 227-230, 243. doi: 10.12206/j.issn.2097-2024.202310007
  • 加载中
WeChat 点击查看大图
计量
  • 文章访问数:  3256
  • HTML全文浏览量:  225
  • PDF下载量:  427
  • 被引次数: 0
出版历程
  • 收稿日期:  2015-03-09
  • 修回日期:  2015-07-06

MDR1基因多态性和单倍体对肾移植术后稳定期患者他克莫司浓度/剂量比值的影响

doi: 10.3969/j.issn.1006-0111.2015.05.008
  • 1. 解放军175医院, 药学科, 福建 漳州 363000
  • 2. 解放军175医院, 泌尿外科, 福建 漳州 363000
    • 基金项目:  漳州市科学技术局科研课题(ZZ2012J27)
  • 收稿日期: 2015-03-09
  • 修回日期: 2015-07-06

摘要: 目的 探讨MDR1 C1236T、G2677T/A和C3435T 基因多态性和单倍体对中国汉族肾移植术后稳定期患者他克莫司浓度/剂量比值的影响,为他克莫司个体化用药提供依据。 方法 采用PCR-基因测序法检测104例肾移植术后稳定期患者MDR1 C1236T、G2677T/A和C3435T 的基因多态性,采用均相酶免疫测定方法(EMIT法)测定他克莫司的谷浓度,比较不同基因型患者之间他克莫司血药浓度/(剂量×体质量)(C/D)比值。 结果 104例患者中,MDR1 C1236T、G2677T/A和C3435T突变频率分别为56.73%、55.77%和33.17%。MDR1 C3435T、MDR1 TTT单倍体与他克莫司C/D比值具有相关性(P<0.05)。CYP3A5*3*3患者中,MDR1 TTT单倍体与他克莫司C/D比值仍存在显著相关(P<0.05)。MDR1 C1236T、G2677T/A、CGC单倍体与他克莫司C/D比值无显著性差异(P>0.05)。 结论 MDR1 C3435T、MDR1 TTT单倍体与中国汉族肾移植术后稳定期患者他克莫司C/D比值具有显著相关性,是影响肾移植患者他克莫司浓度个体化差异的重要因素。

English Abstract

张燕青, 陈锦珊, 李金雨, 林秀丽, 石鹤坤, 林小凤. MDR1基因多态性和单倍体对肾移植术后稳定期患者他克莫司浓度/剂量比值的影响[J]. 药学实践与服务, 2015, 33(5): 415-418. doi: 10.3969/j.issn.1006-0111.2015.05.008
引用本文: 张燕青, 陈锦珊, 李金雨, 林秀丽, 石鹤坤, 林小凤. MDR1基因多态性和单倍体对肾移植术后稳定期患者他克莫司浓度/剂量比值的影响[J]. 药学实践与服务, 2015, 33(5): 415-418. doi: 10.3969/j.issn.1006-0111.2015.05.008
shu
ZHANG Yanqing, CHEN Jinshan, LI Jinyu, LIN Xiuli, SHI Hekun, LIN Xiaofeng. Influence of multidrug resistant gene polymorphisms and haplotype on blood concentration of tacrolimus in individuals in stable phases after renal transplantation[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(5): 415-418. doi: 10.3969/j.issn.1006-0111.2015.05.008
Citation: ZHANG Yanqing, CHEN Jinshan, LI Jinyu, LIN Xiuli, SHI Hekun, LIN Xiaofeng. Influence of multidrug resistant gene polymorphisms and haplotype on blood concentration of tacrolimus in individuals in stable phases after renal transplantation[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(5): 415-418. doi: 10.3969/j.issn.1006-0111.2015.05.008
shu

    全文HTML

参考文献 (13)

目录

    /

    返回文章
    返回

    版权所有：《药学实践与服务》编辑委员会

    主管、主办: 中国人民解放军海军军医大学地址: 上海市杨浦区国和路325号邮政编码: 200433

    电话: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    本系统由 北京仁和汇智信息技术有限公司 开发    百度统计